---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-326916"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2025-12-19T23:59:59+00:00"
generated_at: "2026-05-16T12:36:45.119536+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Inhibikase Therapeutics files prospectus supplement for $185M ATM offering via Jefferies

## Summary
- Inhibikase may sell up to $185M of common stock under existing ATM program through Jefferies LLC.
- Prospectus supplement filed Dec 19, 2025, under registration statement on Form S-3 (File 333-288213).
- Sales Agreement with Jefferies LLC was originally dated June 20, 2025.
- No specific use of proceeds stated; offering conducted from time to time.

## SEC filing metadata
- accession: 0001193125-25-326916
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2025-12-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000119312525326916/0001193125-25-326916-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000119312525326916/d212017d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-326916
- JSON: https://secwatch.observer/filing/0001193125-25-326916.json
- Plain text: https://secwatch.observer/filing/0001193125-25-326916.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.